These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6137430)

  • 21. The relative importance of nervous system and hormones to the 2-deoxy-D-glucose-induced hyperglycemia in fed rats.
    Matsunaga H; Iguchi A; Yatomi A; Uemura K; Miura H; Gotoh M; Mano T; Sakamoto N
    Endocrinology; 1989 Mar; 124(3):1259-64. PubMed ID: 2563682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
    Hollander PM; Asplin CM; Palmer JP
    Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of short-term and prolonged infusions of somatostatin on endocrine pancreas, body weight and food intake in rats.
    Lins PE; Petersson B; Efendić S
    Acta Physiol Scand; 1980 Nov; 110(3):267-75. PubMed ID: 6111176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia.
    Ferrannini E; DeFronzo RA; Sherwin RS
    Am J Physiol; 1982 Feb; 242(2):E73-81. PubMed ID: 7039338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered ability of the liver to produce glucose following a period of glucagon deficiency.
    Deri JJ; Williams PE; Steiner KE; Cherrington AD
    Diabetes; 1981 Jun; 30(6):490-5. PubMed ID: 6112181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
    Staten MA; Matthews DE; Cryer PE; Bier DM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.
    Altszuler N; Gottlieb B; Hampshire J
    Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
    Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of glucagon in mediating metabolic effects of epinephrine.
    Chideckel EW; Goodner CJ; Koerker DJ; Johnson DG; Ensinck JW
    Am J Physiol; 1977 May; 232(5):E464-70. PubMed ID: 404888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptation of B and A cell function during prolonged glucose infusion in human subjects.
    Ward WK; Halter JB; Beard JC; Porte D
    Am J Physiol; 1984 May; 246(5 Pt 1):E405-11. PubMed ID: 6372519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of arginine on splanchnic glucose metabolism in man.
    Bratusch-Marrain P; Björkman O; Hagenfeldt L; Waldhäusl W; Wahren J
    Diabetes; 1979 Feb; 28(2):126-31. PubMed ID: 421970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man.
    Jackson RA; Hamling JB; Blix PM; Sim BM; Hawa MI; Jaspan JB; Belin J; Nabarro JD
    J Clin Endocrinol Metab; 1986 Sep; 63(3):594-604. PubMed ID: 2874153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.